Abstract:Serology routinely serves as a diagnostic tool to confirm Chlamydia infections in humans. Particularly in delayed settings, such as post-outbreak scenarios where the acute phase of infection has subsided, serology is invaluable. Multiple studies, nonetheless, indicate deficiencies in specificity and sensitivity of current chlamydial antibody detection assays. Incorporation of multiple antigens per target is known to improve the accuracy of chlamydial serological assays. We, therefore, used the recomLine test (Mikrogen diagnostics) on serological samples of two cohorts, as it is the only commercially available test allowing detection of antibodies against three human pathogenic Chlamydia species (C. trachomatis, C. pneumoniae and C. psittaci) using multiple antigens per target. The first cohort (n = 156; samples collected between 2008 and 2022 during a C. trachomatis screening initiative) comprised women from the Netherlands (NL) with past exposure to C. trachomatis, while the second cohort (n = 44; samples collected in 2018 in a health examination survey) consisted of Belgian citizens (BE) with occupational or recreational exposure to chickens, representing a risk population for C. psittaci. The test indicated a statistically equivalent C. pneumoniae seroprevalence in both cohorts (39.10% in NL and 34.09% in BE; p = 0.337). As expected C. trachomatis seroprevalence was significantly higher (p < 0.001) in the Dutch cohort (48.72%), as compared to the Belgian cohort (4.55%). Lastly, C. psittaci seroprevalence did not significantly differ between the two groups (2.27% in BE and 1.92% in NL; p = 0.633), even though a higher prevalence was expected for the Belgian cohort. This prompts us to question whether the Belgian cohort truly constituted a C. psittaci risk population or whether the recomLine test is susceptible to cross-reaction of species-specific antibodies, thereby increasing C. psittaci prevalence in the Dutch cohort. We advocate for the development of affordable, highly sensitive antibody detection assays that can effectively distinguish between chlamydial species, addressing the increasing demand for enhanced serological testing methodologies.

Emerging Chlamydia psittaci infections in the chicken industry and pathology of Chlamydia psittaci genotype B and D strains in specific pathogen free chickens.

Chlamydia Psittaci Strains from Broiler Chickens Induce Histopathological Lesions and Mortality in SPF Chickens

Belgian Cross-Sectional Epidemiological Study on Zoonotic Avian Chlamydia spp. in Chickens

Pathogenicity of Low and Highly Virulent Chlamydia Psittaci Isolates for Specific-Pathogen-Free Chickens

Chlamydia Psittaci Infections in Chinese Poultry: a Literature Review

Host-Pathogen Interactions in Specific Pathogen-Free Chickens Following Aerogenous Infection with Chlamydia Psittaci and Chlamydia Abortus

Prevalence of Avian Chlamydophila Psittaci in Suspected Cases Using Three Tests

Molecular Characterization of Atypical Chlamydia and Evidence of Their Dissemination in Different European and Asian Chicken Flocks by Specific Real-Time Pcr

Prevalence and genotypes of Chlamydia psittaci in birds and related workers in three cities of China

Isolation and Characterization of Chlamydophila Psittaci Isolated from Laying Hens with Cystic Oviducts.

Chlamydia Species and Related Risk Factors in Poultry in North-Western Italy: Possible Bird-to-Human Transmission for C. gallinacea

Development of a Novel PmpD-N ELISA for Chlamydia Psittaci Infection

Epidemic Preliminary Investigation of Chlamydophila psittaci in SPF Chicken and Contamination of the Associated Avian Vaccines

Prevalence of avian chlamydophila psittaci in China

Chlamydia gallinacea in Brazilian backyard chicken farms

Challenges in Chlamydial Serology: Insights from a Belgian and a Dutch Population Cohort

Epidemic Investigation of Avian Chlamydia Psittaci in Beijing and Other Provinces Around

Isolation and Characterization of Peacock Chlamydophila Psittaci Infection in China

Isolation and Identification of Pasteurella from Fowl Cholera and the Study of Its Pathogenicity

Case Report: A Case of Chlamydia Psittaci Infection in an HIV Patient

Extensive genomic divergence among 61 strains of Chlamydia psittaci